Novartis says CAR-T cancer therapy works in second lymphoma type

Novartis' cell therapy Kymriah could help treat patients with a type of blood cancer known as follicular lymphoma, potentially supporting the Swiss drugmaker's plans to ask U.S. and European regulators to expand approval of the treatment.